News

Vice President for Research Allen Levine has appointed Michelle Biros, M.D., to serve as deputy institutional official for biomedical studies for the University of Minnesota’s Institutional Review Board, effective May 1, 2018.

Stem cell startup Magenta Therapeutics is developing quickly, thanks in part to a clinical trial agreement with the U's Bone Marrow Transplantation Program. 

The ranking, released by the National Academy of Inventors and the Intellectual Property Owners Association, notes the U of M was awarded 75 patents during calendar year 2017.

This year's Minnesota Cup includes several U of M-launched startups, including enVerde, Farm Vision Technologies, Flyover Country, and Andamio Games.

A list by the Center for World University Rankings placed the U of M 35th among the top universities in the world.

Jeff Shelstad, who was recently named CEO of U ed-tech startup Reflection Sciences, discussed the company's mission in a recent Tech.MN article.

The U of M has commercialized cold-hardy fruit varieties developed by horticultural and wine scientists to create new possibilities for local growers.

The University of Minnesota Office of Budget and Finance has reached an agreement with the Department of Health and Human Services (DHHS) on the FY19 fringe benefit rates.

Dr. Jaime Modiano, who researches how and why cancer occurs in both dogs and humans, recently added two new cell lines to the catalog of reagent company Kerafast, helping researchers worldwide further accelerate cancer research and therapeutic development.

The University of Minnesota Office of Budget and Finance has reached an agreement with the Department of Health and Human Services on the FY19 fringe benefit rates.